Brief: Cabinet Approves Foreign Investment Of Up To 95.89 Billion Rupees In Suven Pharmaceuticals - India Government
13/09/2023 11:02
Sept 13 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* CABINET APPROVES FOREIGN INVESTMENT OF UP TO 95.89 BILLION
RUPEES IN SUVEN PHARMACEUTICALS LIMITED - INDIA GOVERNMENT
Source text for Eikon: ID:
Further company coverage: SUVH.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss